FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

TP Suthar

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Immunohistochemistry

Physiology

Postmenopause

Co-author Network

Publications

TOP 3
JM Bhatavdekar; Devendra D Patel; Neelam G Shah; Hemangini H Vora; TP Suthar; N Ghosh; Priya R Chikhlikar; Trupti I Trivedi
Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
JM Bhatavdekar; Devendra D Patel; Neelam G Shah; Hemangini H Vora; TP Suthar; Priya R Chikhlikar; N Ghosh; Trupti I Trivedi
Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
JM Bhatavdekar; Devendra D Patel; Priya R Chikhlikar; Trupti I Trivedi; N M Gosalia; N Ghosh; Neelam G Shah; Hemangini H Vora; TP Suthar
Overexpression of CD44: a useful independent predictor of prognosis in patients with colorectal carcinomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of TP Suthar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: JM Bhatavdekar; Devendra D Patel; Neelam G Shah; Hemangini H Vora; TP Suthar; N Ghosh; Priya R Chikhlikar; Trupti I Trivedi
Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2000;26(6):540-7.
2000: JM Bhatavdekar; Devendra D Patel; Neelam G Shah; Hemangini H Vora; TP Suthar; Priya R Chikhlikar; N Ghosh; Trupti I Trivedi
Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
Annals of surgical oncology 2000;7(4):305-11.
1998: JM Bhatavdekar; Devendra D Patel; Priya R Chikhlikar; Trupti I Trivedi; N M Gosalia; N Ghosh; Neelam G Shah; Hemangini H Vora; TP Suthar
Overexpression of CD44: a useful independent predictor of prognosis in patients with colorectal carcinomas.
Annals of surgical oncology 1998;5(6):495-501.
1997: JM Bhatavdekar; Devendra D Patel; N Ghosh; Priya R Chikhlikar; Trupti I Trivedi; TP Suthar; S S Doctor; Neelam G Shah; DB Balar
Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
Diseases of the colon and rectum 1997;40(7):785-90.
1997: Devendra D Patel; JM Bhatavdekar; Priya R Chikhlikar; Y V Patel; Neelam G Shah; N Ghosh; TP Suthar; DB Balar
Clinical significance of p53, nm23, and bcl-2 in T3-4N1M0 oesophageal carcinoma: an immunohistochemical approach.
Journal of surgical oncology 1997;65(2):111-6.
1996: Devendra D Patel; JM Bhatavdekar; Priya R Chikhlikar; N Ghosh; TP Suthar; Neelam G Shah; R H Mehta; DB Balar
Node negative breast carcinoma: hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators.
Journal of surgical oncology 1996;62(2):86-92.
1995: JM Bhatavdekar; Devendra D Patel; Neelam G Shah; N H Karelia; H H Vora; N Ghosh; TP Suthar; DB Balar
Prognostic value of insulin-like growth factor-1 receptors in patients with colon/rectal cancer: correlation with plasma prolactin.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(1):23-6.
1994: JM Bhatavdekar; Devendra D Patel; N H Karelia; Neelam G Shah; N Ghosh; H H Vora; TP Suthar; DB Balar; S S Doctor
Can plasma prolactin predict tamoxifen resistance in patients with advanced breast cancer?
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1994;20(2):118-21.
1994: Devendra D Patel; JM Bhatavdekar; N Ghosh; H H Vora; N H Karelia; Neelam G Shah; TP Suthar; DB Balar; C R Trivedi
Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator.
Cancer 1994;73(3):570-4.
1994: JM Bhatavdekar; Devendra D Patel; Priya R Chikhlikar; R H Mehta; H H Vora; N H Karelia; N Ghosh; Neelam G Shah; TP Suthar; J P Neema
Levels of circulating peptide and steroid hormones in men with lung cancer.
Neoplasma 1994;41(2):101-3.
1994: Neelam G Shah; JM Bhatavdekar; S S Doctor; TP Suthar; DB Balar; R S Dave
Circulating epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I) in patients with epithelial ovarian carcinoma.
Neoplasma 1994;41(5):241-3.
1993: JM Bhatavdekar; Devendra D Patel; G V Sherbet; D D Giri; N H Karelia; H H Vora; Neelam G Shah; TP Suthar; S P Nadkarni; DB Balar
Prognostic significance of plasma prolactin in breast cancer: comparison with the expression of c erb B-2 oncoprotein.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1993;19(5):409-13.
1993: JM Bhatavdekar; Devendra D Patel; N H Karelia; TP Suthar; Neelam G Shah; H H Vora; N Ghosh; S P Nadkarni; DB Balar
Correlation of steroid receptors in synchronous tissues with survival in breast cancer patients.
Neoplasma 1993;40(3):177-80.
1992: JM Bhatavdekar; Devendra D Patel; Neelam G Shah; D D Giri; H H Vora; N H Karelia; S N Trivedi; N Ghosh; TP Suthar
Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
Neoplasma 1992;39(1):39-42.